LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.54
(1.89%)
CNY 7.54
(1.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 275.68 Million CNY | 102.49% |
| 2022 | 129.37 Million CNY | -3.85% |
| 2021 | 134.55 Million CNY | 23.04% |
| 2020 | 109.35 Million CNY | 11.21% |
| 2019 | 98.33 Million CNY | -12.84% |
| 2018 | 112.82 Million CNY | 26.33% |
| 2017 | 89.3 Million CNY | 20.49% |
| 2016 | 74.11 Million CNY | 13.47% |
| 2015 | 65.32 Million CNY | -3.24% |
| 2014 | 67.5 Million CNY | -5.67% |
| 2013 | 71.56 Million CNY | 28.98% |
| 2012 | 55.48 Million CNY | -0.52% |
| 2011 | 55.77 Million CNY | -2.97% |
| 2010 | 57.47 Million CNY | 2.47% |
| 2009 | 56.09 Million CNY | -1.08% |
| 2008 | 56.7 Million CNY | 49.13% |
| 2007 | 38.02 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 58.4 Million CNY | 12.01% |
| 2024 Q3 | 49.65 Million CNY | 0.72% |
| 2024 Q1 | 52.14 Million CNY | -34.38% |
| 2023 Q4 | 79.46 Million CNY | 46.95% |
| 2023 FY | 261.96 Million CNY | 102.49% |
| 2023 Q3 | 54.07 Million CNY | -29.22% |
| 2023 Q1 | 52.02 Million CNY | 759.99% |
| 2023 Q2 | 76.39 Million CNY | 46.84% |
| 2022 Q4 | -7.88 Million CNY | -116.29% |
| 2022 Q3 | 48.37 Million CNY | 2.42% |
| 2022 FY | 129.37 Million CNY | -3.85% |
| 2022 Q2 | 47.23 Million CNY | 13.42% |
| 2022 Q1 | 41.64 Million CNY | 269.58% |
| 2021 Q2 | 25.78 Million CNY | -11.6% |
| 2021 Q4 | 11.26 Million CNY | -83.51% |
| 2021 FY | 134.55 Million CNY | 23.04% |
| 2021 Q1 | 29.16 Million CNY | 52.04% |
| 2021 Q3 | 68.33 Million CNY | 165.0% |
| 2020 Q3 | 39.82 Million CNY | 58.35% |
| 2020 Q1 | 25.19 Million CNY | -44.71% |
| 2020 FY | 109.35 Million CNY | 11.21% |
| 2020 Q4 | 19.18 Million CNY | -51.83% |
| 2020 Q2 | 25.15 Million CNY | -0.17% |
| 2019 Q2 | 10.62 Million CNY | -56.43% |
| 2019 Q4 | 45.56 Million CNY | 156.51% |
| 2019 FY | 98.33 Million CNY | -12.84% |
| 2019 Q1 | 24.38 Million CNY | -17.49% |
| 2019 Q3 | 17.76 Million CNY | 67.21% |
| 2018 Q2 | 22.22 Million CNY | -8.65% |
| 2018 FY | 112.82 Million CNY | 26.33% |
| 2018 Q4 | 29.55 Million CNY | -19.53% |
| 2018 Q3 | 36.72 Million CNY | 65.25% |
| 2018 Q1 | 24.32 Million CNY | -30.25% |
| 2017 FY | 89.3 Million CNY | 20.49% |
| 2017 Q3 | 17.1 Million CNY | -5.57% |
| 2017 Q4 | 34.87 Million CNY | 103.93% |
| 2017 Q2 | 18.11 Million CNY | -5.78% |
| 2017 Q1 | 19.22 Million CNY | -29.18% |
| 2016 Q4 | 27.14 Million CNY | 67.05% |
| 2016 Q1 | 15.54 Million CNY | -25.32% |
| 2016 Q2 | 15.18 Million CNY | -2.29% |
| 2016 FY | 74.11 Million CNY | 13.47% |
| 2016 Q3 | 16.24 Million CNY | 6.98% |
| 2015 Q4 | 20.81 Million CNY | 34.01% |
| 2015 Q3 | 15.53 Million CNY | 12.43% |
| 2015 Q2 | 13.81 Million CNY | -8.79% |
| 2015 Q1 | 15.14 Million CNY | -25.16% |
| 2015 FY | 65.32 Million CNY | -3.24% |
| 2014 Q4 | 20.23 Million CNY | 42.88% |
| 2014 Q3 | 14.16 Million CNY | -10.96% |
| 2014 Q2 | 15.9 Million CNY | -7.51% |
| 2014 Q1 | 17.19 Million CNY | 25.31% |
| 2014 FY | 67.5 Million CNY | -5.67% |
| 2013 Q3 | 19.62 Million CNY | -4.7% |
| 2013 Q1 | 17.63 Million CNY | 61.63% |
| 2013 Q4 | 13.72 Million CNY | -30.05% |
| 2013 FY | 71.56 Million CNY | 28.98% |
| 2013 Q2 | 20.58 Million CNY | 16.74% |
| 2012 Q1 | 10.32 Million CNY | 246.83% |
| 2012 Q2 | 14.83 Million CNY | 43.6% |
| 2012 Q3 | 19.41 Million CNY | 30.89% |
| 2012 FY | 55.48 Million CNY | -0.52% |
| 2012 Q4 | 10.91 Million CNY | -43.8% |
| 2011 FY | 55.77 Million CNY | -2.97% |
| 2011 Q4 | 2.97 Million CNY | -87.81% |
| 2011 Q3 | 24.42 Million CNY | 114.22% |
| 2011 Q2 | 11.4 Million CNY | -32.78% |
| 2011 Q1 | 16.96 Million CNY | 15.71% |
| 2010 Q3 | 21.07 Million CNY | 0.0% |
| 2010 Q4 | 14.66 Million CNY | -30.42% |
| 2010 FY | 57.47 Million CNY | 2.47% |
| 2009 FY | 56.09 Million CNY | -1.08% |
| 2008 FY | 56.7 Million CNY | 49.13% |
| 2007 FY | 38.02 Million CNY | 0.0% |